Ken-Ichirou Morishige

Ken-Ichirou Morishige

Auto-generated profile, based on publicly available information

Ken-Ichirou Morishige

Reproductive Medicine Center, Osaka General Medical Center, Osaka, Japan

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Journal of Gynecologic Oncology
Verified
Journal Article
Open access
PDF file
KMKoji Matsuo
Koji Matsuo
MSMuneaki Shimada
Muneaki Shimada
TSTsuyoshi Saito
Tsuyoshi Saito
KTKazuhiro Takehara
Kazuhiro Takehara
HTHideki Tokunaga
Hideki Tokunaga
TSToru Sugiyama
Toru Sugiyama
Matsuo K, et al. J Gynecol Oncol. 2017 Sep;29(1):e11. https://doi.org/10.3802/jgo.2018.29.e11

25 December 2011 in Journal of Oncology
Verified
Journal Article
Open access
PDF file
KSKenjiro Sawada
Kenjiro Sawada
COChifumi Ohyagi-Hara
Chifumi Ohyagi-Hara
TKTadashi Kimura
Tadashi Kimura
KMKen-Ichirou Morishige
Ken-Ichirou Morishige
Ovarian cancer is a deadly disease, with a cure rate of only 30%. Despite aggressive treatments, relapse remains almost inevitable in patients with advanced-stage disease. In recent years, great progress has been made towards targeting integrins in cancer treatment, and clinical studies with various integrin inhibitors have demonstrated their effectiveness in blocking cancer progression. Given that the initial critical step of ovarian cancer metastasis is the attachment of cancer cells onto the peritoneum or omentum, in addition to the proven positive clinical results of anti-angiogenic therapy, targeting integrins is likely to be one of the most feasible approaches. This paper summarizes the current understanding of the integrin biology in ovarian cancer metastasis and the various therapeutic approaches attempted with integrin inhibitors. Although no integrin inhibitors have shown favorable results so far, integrin-targeted therapies continue to be a promising approach to be explored for further clinical investigation.

28 July 2015 in SpringerPlus
Verified
Journal Article
Open access
PDF file
SASayed Ahmad Zikri B Sayed Aluwee
Sayed Ahmad Zikri B Sayed Aluwee
HKHiroki Kato
Hiroki Kato
XZXiangrong Zhou
Xiangrong Zhou
THTakeshi Hara
Takeshi Hara
HFHiroshi Fujita
Hiroshi Fujita
KMKen-Ichirou Morishige
Ken-Ichirou Morishige
This study aimed to assess the efficacy of 3D surface-rendered (SR) magnetic resonance (MR) images for surgical planning of uterine fibroids. Ten patients with uterine fibroids underwent 3D volume isotropic turbo spin-echo acquisition (VISTA) sequences in sagittal planes. SR images showing the uterine body, endometrium, and fibroids were extracted from the raw MR data. The preoperative assessment for fertility-preserving fibroid enucleation was independently performed by two gynecologists using 2D sagittal and 3D SR images separately. The required interpretation times [second] for sagittal versus SR images were 19.7 ± 9.5 versus 10.4 ± 5.1 for observer 1 (p < 0.05) and 47.5 ± 12.3 versus 19.7 ± 9.5 for observer 2 (p < 0.01). The accuracy rates of the planned surgical procedures from sagittal versus SR images were 50 versus 70% for observer 1 and 70 versus 70% for observer 2. The accuracy rates of the numbers of fibroids to be removed from sagittal versus SR images were 70 versus 80% for observer 1 and 70 versus 80% for observer 2. Compared with sagittal images, SR images could significantly reduce the time required for surgical planning of uterine fibroids without sacrificing the accuracy of the preoperative assessment.

1 February 2015 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
NNNoriko Nozawa-Suzuki
Noriko Nozawa-Suzuki
HNHideko Nagasawa
Hideko Nagasawa
KOKen Ohnishi
Ken Ohnishi
KMKen-Ichirou Morishige
Ken-Ichirou Morishige

1 June 2017 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
MTMotoki Takenaka
Motoki Takenaka
NSNoriko Suzuki
Noriko Suzuki
MMMinako Mori
Minako Mori
THTasuku Hirayama
Tasuku Hirayama
HNHideko Nagasawa
Hideko Nagasawa
KMKen-Ichiro Morishige
Ken-Ichiro Morishige

1 March 2019 in British Journal of Radiology
Verified
Journal Article
Closed access
MKMasaya Kawaguchi
Masaya Kawaguchi
HKHiroki Kato
Hiroki Kato
ナすナツコ すずい
ナツコ すずい
TFTatsuro Furui
Tatsuro Furui
KMKen-Ichirou Morishige
Ken-Ichirou Morishige
MMMasayuki Matsuo
Masayuki Matsuo
This study aimed to assess the efficacy of MRI for differentiating between uterine submucosal polypoid adenomyomas (PAs) and endometrial polyps (EPs). MRI was used to examine 40 histopathologically confirmed benign polypoid endometrial tumors (8submucosal PAs and 32 EPs). Atypical PAs were excluded from this study. Quantitative measurements (maximum tumor diameter, maximum cyst diameter, number of cysts, and apparent diffusion coefficient values) and qualitative imaging findings (predominance of cystic or solid components as well as presence of cysts, hemorrhage, myometrial invasion, fluid-fluid level, and fibrous core) were correlated with the two pathologies. The predominance of cystic components (37% vs 6%; p < 0.05) was more frequently observed in PAs than in EPs. The frequency of cysts (88% vs 25%; p < 0.01), hemorrhage (50% vs 9%; p < 0.05), and myometrial invasion (25% vs 0%; p < 0.05) were significantly higher in PAs than in EPs. No significant differences were observed in terms of the maximum tumor diameter, maximum cyst diameter, number of cysts, apparent diffusion coefficient values, and presence of fluid-fluid level and fibrous core between PAs and EPs. The differences of MR findings with emphasis on cystic components and hemorrhage may be useful for differentiating between PAs and EPs. The predominance of cystic or solid components and the presence of cysts, hemorrhage, and myometrial invasion were useful MR findings for differentiating between PAs and EPs.